Design of novel synthetic promoters to tune gene expression in T cells
Bonfa, G.; Martino, G.; Sellitto, A.; Rinaldi, A.; Tedeschi, F.; Caliendo, F.; Melchiorri, L.; Perna, D.; Starkey, F.; Nikolados, E.; Menolascina, F.; Siciliano, V.
Show abstract
Transcriptional control of transgene expression can be linked to dynamic changes in cellular states if this is accompanied by differential expression of transcription factors (TFs). Synthetic promoters (SPs) designed to respond to the desired TFs can provide this regulation with compactness, specificity, and orthogonality. T cells display differentially expressed TFs according to the functional state. In solid tumors, the highly immunosuppressive TME and the chronic exposure to antigens lead to a progression of T cells from a functional to a dysfunctional state known as exhaustion (Tex), in which their power against cancer cells is strongly compromised. Importantly, this transition is accompanied by a marked increase of several TFs, among other factors, that drive targeted genetic programs. Strategies to detect and mitigate Tex are extremely needed. Here, we design SPs that respond to TFs differentially expressed in activated and exhausted T cells to enable new classifiers of the functional/dysfunctional states. We developed a library of over 80 SPs responsive to 7 TFs. The SPs showed broad strength of activation of reporter genes or immunomodulatory molecules in HEK293 and Jurkat T cell lines. Moreover, using a transfer learning strategy we show SPs strength predictability. By combining SPs responding to different TFs, we created Boolean logic gates and implemented a feed-forward design that was previously shown to reduce noise in the OFF-state. Finally, as proof of principle, we demonstrate the dynamic activation of the NR4A2-responsive SP according to the T cell state in primary human CD8+ T cells. Collectively we present a sensing platform that provides a versatile tool to study and monitor the dynamic changes occurring in T cells. In perspective the biosensors coupled to therapeutic genes can be used to reprogram the TME and reinvigorate the T cell anti-tumoral functionality, preventing or reverting the exhausted phenotype. Graphical AbstractCreated with BioRender.com. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=108 SRC="FIGDIR/small/632034v1_ufig1.gif" ALT="Figure 1"> View larger version (36K): org.highwire.dtl.DTLVardef@136e147org.highwire.dtl.DTLVardef@22e5org.highwire.dtl.DTLVardef@f2e863org.highwire.dtl.DTLVardef@176c02c_HPS_FORMAT_FIGEXP M_FIG C_FIG
Matching journals
The top 2 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Optimizing a CRISPR-Cas13d gene circuit for tunable target RNA downregulation with minimal collateral RNA cutting 96%
- Engineering a novel probiotic toolkit in Escherichia coli Nissle1917 for sensing and mitigating gut inflammatory diseases 96%
- Degron-based bioPROTACs for controlling signaling in CAR T cells 95%
Similar papers in this journal
- Deep-learning-assisted Sort-Seq enables high-throughput profiling of gene expression characteristics with high precision 95%
- Pharmacological modulators of epithelial immunity uncovered by synthetic genetic tracing of SARS-CoV-2 infection responses 94%
- Multiplexed whole animal imaging with reversibly switchable optoacoustic proteins 94%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.